KOSPI Composite Index Rises 0.70% This Week to 2593.37 — Data Talk
The KOSPI Composite Index is up 17.96 points or 0.70% this week to 2593.37
--Up for two consecutive weeks
--Up 49.09 points or 1.93% over the last two weeks
--Largest two-week point and percentage gain since the week ending Aug. 23, 2024
--Up four of the past six weeks
--Today it is up 12.57 points or 0.49%
--Up for four consecutive trading days
--Up 80.00 points or 3.18% over the last four trading days
--Largest four-day point and percentage gain since Friday, Aug. 16, 2024
--Longest winning streak since Friday, Aug. 16, 2024, when the market rose for five straight trading days
--Off 21.54% from its record close of 3305.21 hit Tuesday, July 6, 2021
--Highest closing value since Tuesday, Sept. 3, 2024
--Off 10.31% from its 52-week high of 2891.35 hit Thursday, July 11, 2024
--Up 13.84% from its 52-week low of 2277.99 hit Tuesday, Oct. 31, 2023
--Rose 3.40% from 52 weeks ago
--Off 10.31% from its 2024 closing high of 2891.35 hit Thursday, July 11, 2024
--Up 6.46% from its 2024 closing low of 2435.90 hit Wednesday, Jan. 17, 2024
--Month-to-date it is down 3.03%
--Year-to-date it is down 61.91 points or 2.33%
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
September 20, 2024 06:52 ET (10:52 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
Undervalued by 25% and Yielding 5%, This Stock Is a Buy
-
Can AI Predict Future Stock Returns?
-
The Best Energy Stocks to Buy Now
-
10 Undervalued Wide-Moat Stocks
-
Obesity Drugs: Can New Firms Take Market Share From Eli Lilly and Novo Nordisk?
-
New 4-Star Stocks
-
Intel Fair Value Left Unchanged Despite Qualcomm Takeover Talk